{"version":"1.0","type":"link","title":"A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.","author_name":"Wenham RM 외","author_url":"https://prs-insight.online/author/Wenham%20RM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169651","thumbnail_width":1200,"thumbnail_height":630}